Stocks

Magazine articles on individual stocks, valuation, accounting standards, IPO's, brokerages, exchanges.

Old Articles: <Older 281-290 Newer>

BusinessWeek November 3, 2003 Christopher Palmeri	Qwest: Off The Critical List, But... Cash on hand doesn't help a declining core business and big accounting probes
BusinessWeek November 3, 2003 Laura Cohn	Where Offshore Funds Are Finding Gems In 2003, investors saw sizzling gains in Russia, Thailand, Eastern Europe, and Brazil. And there may be more to come.
BusinessWeek November 3, 2003 William C. Symonds	Commentary: The Kodak Revolt Is Short-Sighted Digital is the only way to go, but Kodak CEO Daniel A. Carp must prove he can deliver -- fast.
BusinessWeek November 3, 2003 Cliff Edwards	Palm Reaches Out For A Hand But will a merger with Handspring be enough to fend off ferocious rivals?
BusinessWeek November 3, 2003 Frederik Balfour	Thai Investing: More Thrills Ahead? For the year ended Sept. 30, the Stock Exchange of Thailand index finished up 73.51% in baht terms, or 86.72% when the results are converted to dollars. With gains like that, it's easy for investors to think they've missed the boat. But analysts remain bullish.
Search Engine Watch October 24, 2003 Danny Sullivan	Google Buys Sprinks, Plans IPO In a busy financial day for Google, the company purchased Sprinks, the former paid listings division of PRIMEDIA's About.com, while it was also revealed that an initial public offering is planned for early next year.
BusinessWeek November 3, 2003	Handhelds Are Clicking Bernie Schaeffer, who runs Schaeffer's Investment Research, is hot on techs -- even after their huge rally. Investors are rubbing their eyes, "unconvinced that techs are really back," he says. The euphoria of the '90s is still not in sight, so he reckons techs have room to run.
BusinessWeek November 3, 2003	Spectrum's New Cancer Weapons Several big investors have been buying little-known Spectrum Pharmaceuticals, which develops anticancer agents that have previous clinical data to back their efficacy and safety.
BusinessWeek November 3, 2003	The Heavy Trading In Strategic Diagnostics Strategic Diagnostics, which makes immunoassay tests to detect toxicity in foodstuffs, has risen since September from 3.90 to 4.87 -- on heavy volume. Herbert Lotman, who owns Keystone Foods and sits on Strategic's board, has been buying shares, and it is rumored that he may make a run for Strategic.
BusinessWeek October 27, 2003 Robert Barker	Too Late To Jump Back Into Tyco? At $22 a share, Tyco has nearly doubled from its low in March. Given Tyco's new financial basis and outlook, the question for investors is whether the stock remains a growth opportunity.
<Older 281-290 Newer> Return to current articles.